The MAPK/ERK signaling pathway is another critical target for inhibitors. This pathway is associated with regulating cell survival, differentiation, and growth. Inhibitors targeting MAPK/ERK are used in cancer therapies to avoid unrestrained cell spreading and lump development. Similarly, JAK/STAT signaling inhibitors modulate immune actions and ar